Oculis
Other - Zug, Zug, CH
Oculis Employees
Gudrun Asgrimsdottir
Pharmaceutical Development VP and Iceland Site & Lab Head
Naleni Eigensatz-Sears
Office Manager & Executive Assistant to CEO & CFO
Oculis Senior Management
Naleni Eigensatz-Sears
Office Manager & Executive Assistant to CEO & CFO
Oculis Details
Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal is to improve the health and quality of life of patients worldwide. The company is led by an experienced management team with a successful track record and is supported by leading international healthcare investors. For more information, please visit: www.oculis.com
Oculis Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Other
Mobile Friendly